Search - tctmd.com

Displaying 21 - 40 of 165

Sort: Relevancy | Date

Presentation TCT 2023

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

Presenter: SIMONE FEZZI

October 25, 2023

Presentation TCT 2023

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

Presenter: Stefano Galli

October 25, 2023

Presentation TCT 2023

TCT 699: Preclinical evaluation of a thin-strut biodegradable stent in a porcine coronary artery restenosis model

Presenter: Piotr Buszman

October 25, 2023

Presentation TCT 2023

TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days

Presenter: Sho Torii

October 25, 2023

Presentation TCT 2023

TCT 576: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final 5 Year Clinical Outcomes

Presenter: Matthias Lutz

October 25, 2023

Presentation TCT 2023

TCT 81: Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 36-Month Outcomes of the BIOSOLVE-IV Registry

Presenter: Gregory Starmer

October 25, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

Presentation TCT 2022

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 63: Long-term Outcomes of bioabsorbable magnesium scaffold in acute coronary syndromes

Presenter: Alejandro Gutierrez-Barrios

September 17, 2022

Presentation TCT 2022

TCT 62: Novel, Biodegradable PLA/PLGA Amorphous Polymer Scaffold In The Porcine Coronary Restenosis Model.

Presenter: Piotr Buszman

September 17, 2022

Presentation TCT 2022

TCT 61: Safety and efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 24-month Follow-up of the Full Cohort (2066 subjects) of the BIOSOLVE-IV Registry

Presenter: Johan Bennett

September 17, 2022

Presentation TCT 2022

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

Presenter: Mick Renkens

September 17, 2022

Presentation TCT 2022

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

Presenter: Giulia Masiero

September 17, 2022

Presentation TCT 2022

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

Presenter: Matthias Lutz

September 17, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

Presentation TCT 2022

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Presenter: Marta Konopko

September 17, 2022

News Conference News TCT 2021

Good Long-term Results With FANTOM BVS, but More Data Needed

Michael O'Riordan

October 21, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Daily News CRT 2021

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Michael O'Riordan

March 17, 2021

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Advertisement

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

TCT 141: Preliminary Results of the Resorbable Magnesium Scaffold (Magmaris) in long and multivessel lesions: data from the IT-Masters registry

TCT 699: Preclinical evaluation of a thin-strut biodegradable stent in a porcine coronary artery restenosis model

TCT 591: Preclinical Evaluation of a Novel Bioresorbable Sirolimus Eluting Magnesium-Alloy Scaffold in a Healthy Swine Coronary Arteries up to 540 Days

TCT 576: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final 5 Year Clinical Outcomes

TCT 81: Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 36-Month Outcomes of the BIOSOLVE-IV Registry

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

TCT 64: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – 3 Clinical Year Outcomes

TCT 63: Long-term Outcomes of bioabsorbable magnesium scaffold in acute coronary syndromes

TCT 62: Novel, Biodegradable PLA/PLGA Amorphous Polymer Scaffold In The Porcine Coronary Restenosis Model.

TCT 61: Safety and efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting – 24-month Follow-up of the Full Cohort (2066 subjects) of the BIOSOLVE-IV Registry

TCT 60: The impact of implantation techniques in Absorb BVS and Xience EES on lesion oriented-outcomes at complete five-year follow-up – an AIDA trial QCA substudy

TCT 59: Impact of prolonged dual antiplatelet therapy duration on bioresorbable scaffolds outcomes: five-year data from a prospective registry.

TCT 58: FANTOM II Trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – Final: 5 Year Clinical Outcomes

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

TCT 56: Long-term outcomes after bioresorbable vascular scaffold implantation in patients with de-novo coronary artery disease.

Good Long-term Results With FANTOM BVS, but More Data Needed

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content